ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 79 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,871,444 | -50.0% | 8,262,042 | -10.3% | 0.00% | -42.9% |
| Q2 2023 | $87,797,848 | -56.4% | 9,212,786 | -49.7% | 0.01% | -22.2% |
| Q1 2023 | $201,573,460 | +49.0% | 18,324,860 | +100.5% | 0.01% | -30.8% |
| Q4 2022 | $135,259,760 | -20.7% | 9,139,173 | +2.4% | 0.01% | -27.8% |
| Q3 2022 | $170,637,000 | +3.8% | 8,929,231 | +15.8% | 0.02% | +12.5% |
| Q2 2022 | $164,357,000 | +12.9% | 7,712,680 | +2.1% | 0.02% | +33.3% |
| Q1 2022 | $145,558,000 | -7.0% | 7,557,593 | +0.2% | 0.01% | 0.0% |
| Q4 2021 | $156,467,000 | -13.1% | 7,544,212 | +0.1% | 0.01% | -14.3% |
| Q3 2021 | $180,041,000 | -12.4% | 7,536,265 | +0.1% | 0.01% | -12.5% |
| Q2 2021 | $205,514,000 | -7.0% | 7,530,740 | -1.4% | 0.02% | -15.8% |
| Q1 2021 | $220,922,000 | +20.0% | 7,636,449 | +16.7% | 0.02% | +18.8% |
| Q4 2020 | $184,116,000 | +9.7% | 6,545,164 | +14.3% | 0.02% | -5.9% |
| Q3 2020 | $167,842,000 | -3.0% | 5,728,393 | +0.1% | 0.02% | -10.5% |
| Q2 2020 | $173,069,000 | +1.7% | 5,723,182 | +0.2% | 0.02% | -20.8% |
| Q1 2020 | $170,258,000 | – | 5,713,343 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $46,113,272 | 3.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $5,869,191 | 2.34% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $15,930,000 | 1.78% |
| Sio Capital Management, LLC | 635,969 | $3,376,995 | 1.04% |
| Rubric Capital Management LP | 5,034,530 | $26,733,354 | 1.00% |
| Tejara Capital Ltd | 309,179 | $1,641,740 | 0.93% |
| AlphaCentric Advisors LLC | 165,000 | $876,150 | 0.50% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,135,227 | $6,028,055 | 0.33% |
| Orbimed Advisors | 1,914,479 | $10,165,883 | 0.22% |
| Two Seas Capital LP | 164,807 | $875,125 | 0.18% |